Well I told my doctor about this company and the feedback I got that was based on the AGM report was that Glass and Garners CVs are impressive. Also that INV102 would be off to a good start with a known safety profile but that Cpn10 was the most interesting.
I guess I have a personal interest as I have bronchitis from time to time and INV102 sounds good to me. I wish it had been on the market 2 months ago.
So where is the news?
2 not 1 - Two trials commencing by end of 2012?
Questions to be answered -
1. Have all the required candidates for the trials been enrolled?
2.Have the trials commenced? If so when and where?
3. Estimated end dates of trials, data collection and results.
I would have thought we would have been getting a steady trickle of announcements re progress on these.
I will send an email to Investor Relations and let you know if I receive a reply.
Add to My Watchlist
What is My Watchlist?
